Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
Top Cited Papers
Open Access
- 1 December 2002
- journal article
- research article
- Published by Elsevier BV in Developmental Cell
- Vol. 3 (6), 889-901
- https://doi.org/10.1016/s1534-5807(02)00369-6
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002
- Linkage of M-CSF Signaling to Mitf, TFE3, and the Osteoclast Defect in Mitfmi/mi MiceMolecular Cell, 2001
- Tissue-specific and Ubiquitous Promoters Direct the Expression of Alternatively Spliced Transcripts from the Calcitonin Receptor GenePublished by Elsevier BV ,2001
- Carbonic anhydrase II is an AP‐1 target gene in osteoclastsJournal of Cellular Physiology, 2001
- Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2000
- Fosl1 is a transcriptional target of c-Fos during osteoclast differentiationNature Genetics, 2000
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and FunctionAnnual Review of Immunology, 1997
- THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVOTransplantation, 1994
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991